Authors: Waalewijn H, Mujuru HA, Amuge P, Cotton M, Bollen P, Chan M, Ali S, Variavan E, Makumbi S, Colbers A, Gibb D, Ford D, Burger D, Turkova A, and the ODYSSEY-trial teamPublished in: Oral presentation at 27th Conference on Retroviruses and Opportunistic...
Adeqaute dolutegravir exposure dosed BID with rifampicin in children 6 to < 18 years
read more